Authors: Pham TM, Carpenter JR, Chan M, DeMasi R, Ford D, Gan K, Hopking J, Huang JO, Liao Q, Turkova A, Wang Y, White IR Presented at: International Clinical Trials Methodology Conference Read
Search
results
Search
ResultsPredictors of Viral Rebound in Children Living with HIV Initiating Second-Line Antiretroviral Therapy in the ODYSSEY and CHAPAS-4 Trials
Authors: Amuge P, Wyncoll J, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kityo CM, Chabala C, Nyathi M, Nduna B, Musoke P, Srirompotong U, Violari A, Archary M, Cotton M, Mulenga V, Bwakura-Dangarembizi M, Elyanu PJ, Yawe I, Kaudha E, Musoro G, Ankunda R, Ndebele W,...
T-cell subsets, T-cell receptor repertoire and HIV-1 virological reservoir in children initiating first-line dolutegravir versus standard-of-care ART: results from the ODYSSEY trial
Authors: Gärtner K, Wyncoll J, Hammer ASB, Rattenborg MN, Adams S, Byott M, Alber D, Botha JC, Kekitiinwa AR, Kityo C, Bamford A, Bwakura-Dangarembizi M, Violari A, Ounchanum P, Lugemwa A, Rojo P, Giaquinto C, Gibb D, Ford D, Turkova A, Sandgaard KS, Nastouli E;...
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial
Authors: Mujuru HA, White E, Kekitiinwa AR, Lugemwa A, Kityo C, Violari A, Ahimbisibwe GM, Variava E, Archary M, Cotton M, Ounchanum P, Puthanakit T, Kanjanavanit S, Ngampiyaskul C, Kobbe R, Bandi S, Epaiza C, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Kaudha E,...
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial
Authors: Wyncoll J, Kamolrattana R, Archary M, Mujuru HA, Kekitiinwa AR, Violari A, Na-Rajsima S, Lugemwa A, Variava E, Cotton M, Kityo CM, Königs C, Behuhuma NO, Welch S, Saïdi Y, Marques L, Ahimbisibwe GM, Houlden L, Giaquinto C, Rojo P, Gibb DM, Puthanakit T,...
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial
Authors: Chan MK, Crichton S, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kityo CM, Ahimbisibwe GM, Variava E, Violari A, Cotton M, Archary M, Cressey TR, Puthanakit T, Bandi S, Bwakura-Dangarembizi M, Bbuye D, Atwine L, Kaudha E, White E, Giaquinto C, Rojo P, Gibb DM,...
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial
Authors: Turkova A, White E, Violari A, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kaudha E, Na-Rajsima S, Ahimbisibwe GM, Variavae E, Archary M, Akhalwaya Y, Puthanakit T, Bwakura-Dangarembizi M, Bbuye D, Kasozi M, Liberty A, Königs C, Welch SB, Riault Y, Bamford A,...
Growth trajectories before and after switching to dolutegravir in children living with HIV in the ODYSSEY trial
Authors: Chan MK, Crichton S, Mujuru HA, Kekitiinwa AR, Lugemwa A, Kityo CM, Ahimbisibwe GM, Variava E, Violari A, Cotton M, Archary M, Cressey TR, Puthanakit T, Bandi S, Bwakura-Dangarembizi M, Bbuye D, Atwine L, Kaudha E, White E, Giaquinto C, Rojo P, Gibb DM,...
Pregnancies among adolescents and young women on dolutegravir vs standard-of-care in the ODYSSEY trial and effects of the dolutegravir neural tube defect safety alert
Authors: Ahimbisibwe G, Wyncoll J, Mngqibisa R, White E, Bwakura-Dangarembizi M, Kekitiinwa AR, Lugemwa A, Kityo CM, Variava E, Liberty A, Kataike H, Ngampiyaskul C, Cotton MF, Riault Y, Archary M, Smit T, Puthanakit T, Shakeshaft C, Nhema R, Bbuye D, Atwine L, Kaudha...
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial
Authors: Wyncoll J, Archary M, Kamolrattana R, Mujuru HA, Kekitiinwa AR, Violari A, Na-Rajsima S, Lugemwa A, Variava E, Cotton M, Kityo CM, Puthanakit T, Königs C, Behuhuma O, Welch S, Saïdi Y, Marques L, Ahimbisibwe GM, Holden L, Giaquinto C, Rojo P, Gibb DM, Turkova...

